Diacerein
Diacerein is used in the treatment of osteoarthritis. Diacerein is a proteoglycan synthesis stimulator. It works by building cartilage (soft connective tissue around the joints) leading to joint repair. It also lowers pain and inflammation (swelling).
| Product dosage: 50 mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 30 | $1.67 | $50.00 (0%) | 🛒 Add to cart |
| 60 | $1.23 | $100.00 $74.00 (26%) | 🛒 Add to cart |
| 90 | $1.10 | $150.00 $99.00 (34%) | 🛒 Add to cart |
| 120 | $1.01 | $200.00 $121.00 (40%) | 🛒 Add to cart |
| 180 | $0.92
Best per cap | $300.00 $165.00 (45%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Abana: Natural Cardiovascular Support for Optimal Heart Health
Abana is a clinically studied, multi-herbal formulation designed to support cardiovascular wellness and maintain healthy cholesterol levels already within the normal range. This expert-formulated supplement combines time-tested Ayurvedic herbs with modern pharmacological understanding to provide a holistic approach to heart health. It functions by promoting healthy lipid metabolism, supporting arterial elasticity, and providing antioxidant protection against oxidative stress. For individuals seeking a natural adjunct to a heart-healthy lifestyle, Abana offers a scientifically grounded option backed by traditional use and contemporary research.
Accupril: Effective Blood Pressure Control for Cardiovascular Health
Accupril (quinapril hydrochloride) is an angiotensin-converting enzyme (ACE) inhibitor prescription medication specifically formulated for the management of hypertension and heart failure. As a frontline therapeutic agent, it works by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing peripheral arterial resistance. This mechanism of action makes it a cornerstone in cardiovascular risk reduction strategies, particularly for patients requiring comprehensive blood pressure management alongside other cardiovascular conditions.
Actigall: Effective Dissolution Therapy for Gallstones
Actigall (ursodiol) is a bile acid medication specifically formulated to dissolve certain types of gallstones in patients for whom surgery poses an unacceptable risk. It works by reducing the cholesterol saturation of bile, thereby promoting the gradual dissolution of radiolucent, non-calcified cholesterol stones in a functioning gallbladder. This oral therapy represents a non-surgical alternative for a carefully selected patient population, offering a targeted approach to managing symptomatic gallstone disease under expert medical supervision.
Actonel: Clinically Proven to Increase Bone Mineral Density
Actonel (risedronate sodium) is a bisphosphonate medication specifically formulated for the treatment and prevention of osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. It works by inhibiting osteoclast-mediated bone resorption, thereby slowing bone loss, reducing the risk of fractures, and promoting a positive bone remodeling balance. This oral tablet is a cornerstone of pharmacological management for bone density conditions, offering a well-tolerated profile with proven long-term efficacy in maintaining skeletal integrity.
Aggrenox: Dual-Antiplatelet Protection Against Recurrent Stroke
Aggrenox is a prescription medication specifically formulated to reduce the risk of recurrent ischemic stroke in patients who have experienced a prior stroke or transient ischemic attack (TIA). It combines two active antiplatelet agents—aspirin and dipyridamole—in an extended-release formulation designed to work synergistically. This combination therapy targets distinct pathways of platelet aggregation, offering a comprehensive approach to secondary stroke prevention. By inhibiting clot formation through complementary mechanisms, Aggrenox provides a robust therapeutic option backed by clinical evidence demonstrating significant risk reduction compared to monotherapy approaches.
Albendazole: Broad-Spectrum Anthelmintic for Effective Parasite Eradication
Albendazole is a benzimidazole carbamate anthelmintic agent with broad-spectrum activity against intestinal and tissue-dwelling nematodes and cestodes. This synthetic compound demonstrates vermicidal and ovicidal properties by selectively binding to beta-tubulin in parasitic cells, inhibiting microtubule polymerization and disrupting glucose uptake. Its extensive first-pass metabolism produces the active sulfoxide metabolite, which achieves therapeutic concentrations in various tissues, including cysts, making it particularly effective against systemic parasitic infections. The medication represents a cornerstone in antiparasitic therapy due to its proven efficacy, well-established safety profile, and cost-effectiveness in managing helminthic infestations.
Alfacip: Advanced Vitamin D Therapy for Optimal Bone Health
Alfacip is a high-potency prescription medication containing the active form of Vitamin D, calcitriol, designed to manage and prevent conditions associated with calcium and phosphate metabolism disorders. It is specifically indicated for patients with chronic kidney disease, hypoparathyroidism, and certain types of rickets or osteomalacia where endogenous Vitamin D synthesis or activation is impaired. By directly providing biologically active calcitriol, Alfacip ensures efficient intestinal calcium absorption, promotes bone mineralization, and helps maintain serum calcium levels within the physiological range, reducing the risk of skeletal complications and supporting overall metabolic balance.
Alkeran: Targeted Chemotherapy for Multiple Myeloma
Alkeran (melphalan) is a potent alkylating chemotherapeutic agent specifically indicated for the treatment of multiple myeloma and palliative management of advanced ovarian carcinoma. As a nitrogen mustard derivative, it exerts its cytotoxic effects by cross-linking DNA strands, thereby inhibiting tumor cell replication and proliferation. Its targeted mechanism and established efficacy profile make it a cornerstone in specific oncologic treatment protocols, particularly within hematologic malignancies. This product card provides a comprehensive, expert-level overview of its clinical application, safety profile, and pharmacologic characteristics for healthcare professionals.
Arimidex: Advanced Aromatase Inhibition for Breast Cancer Treatment
Arimidex (anastrozole) represents a significant advancement in endocrine therapy for hormone receptor-positive breast cancer in postmenopausal women. As a third-generation aromatase inhibitor, it specifically targets the aromatase enzyme system responsible for estrogen production. This medication has demonstrated superior efficacy compared to traditional anti-estrogen therapies in multiple clinical trials, establishing itself as a cornerstone in both adjuvant and metastatic treatment settings. The selective mechanism of action minimizes estrogen synthesis without affecting other steroid hormone pathways, offering a targeted approach to hormone-sensitive malignancies.